News

Psychiatrists advocate for mental health rights amid political turmoil, urging reconsideration of harmful health policies affecting vulnerable populations.

Onfasprodil shows promise as a rapid treatment for resistant depression, offering fewer side effects than ketamine in recent clinical trials.

Half of patients with stuttering also experience anxiety, highlighting the psychiatrist’s role in care and support.

FDA clears accelerated deep TMS protocol for major depressive disorder, offering faster treatment with similar outcomes and fewer visits.

Combining cognitive behavioral therapy with medication enhances ADHD treatment in adults, showing significant benefits within 3 months.

Adial Pharmaceuticals has received feedback from FDA on the AD04 phase 3 adaptive clinical trial design and broader clinical development strategy.

Peer mentoring enhances psychiatric care by supporting new providers, reducing burnout, and fostering collaboration among NPs and PAs in mental health.

Timing hormone replacement therapy post menopause significantly influences Alzheimer disease risk, with early treatment offering protective benefits against cognitive decline.

Chatbots engage youth with connection but pose serious risks, potentially harming mental health and fostering unhealthy attachments. Awareness and regulation are crucial.

"What they taught in school was not what we needed, and what we needed (they said) could not be conveyed."

Explore the impact of moral injuries on health care workers and the need for systemic change to support their well-being and mental health.

Discover effective strategies to build resilience and thrive through life's challenges, from personal growth to support systems and professional help.

New research highlights the effectiveness of early psychosis intervention programs, emphasizing low caseloads and clozapine access to reduce relapse rates.

Explore the evolving landscape of moral injury treatment in health care, emphasizing trust, advocacy, and innovative therapeutic approaches.

America is in the world, the world is in America.

Shelly Jo Kraft, MS, PhD, lays the foundation for a new approach that emphasizes the role of comorbidities in stuttering.

Collaborating with speech pathologists and others improve care for patients who stutter.

Gerald A. Maguire, MD, details the unmet needs in stuttering at the inaugural conference.

Simplistic explanations and convenient scapegoats belie the complexity of mass shootings.

Cognitive behavioral therapy for insomnia effectively treats chronic insomnia, promoting long-term sleep improvement through targeted behavioral strategies.

Moral injuries in health care professionals became an increasing focus during the COVID-19 pandemic, with all the obstacles, uncertainty, and risks of patient care.

More than 20 years later, what have we learned about PTSD, resiliency, and trauma?

Oregon's "Create Resilience" Youth Art Contest celebrates creativity in mental health, showcasing powerful youth submissions that inspire hope and connection.

It is time to redefine treatment resistance, a definition in which we emphasize comprehensive evaluations and personalized approaches for better patient outcomes.

An expert expresses concerns over NRx-100's "expanded access" for ketamine, questioning its safety claims and prioritizing market strategy over patient care.

This article explores the lasting impact of 9/11 on mental health, moral injury, and the role of first responders in crisis situations.

Frank A. Clark, MD, reflects on current state of our country.

Takeda's oveporexton shows promising results in treating narcolepsy type 1, significantly improving symptoms and quality of life in clinical trials.

Christine Yu Moutier, MD, discusses suicide prevention strategies, highlighting risk factors and the importance of culturally competent care for vulnerable populations.